Can Kandu’s IpsiHand brain-computer interface reopen the recovery window after stroke?
Randomized trial data show the FDA-cleared IpsiHand brain-computer interface improved chronic stroke recovery. Find out what this changes for rehab care.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Medtronic secures FDA clearance for Stealth AXiS surgical system in spine robotics
Medtronic wins FDA clearance for Stealth AXiS in spine robotics. Explore what this integrated platform means for workflow, data, and adoption.
Medical Devices & Diagnostics
Does WHOOP’s biomarker integration move wearables closer to regulated healthcare?
WHOOP launches Advanced Labs in the UAE with Unilabs, integrating 65 biomarkers into its wearable platform. Explore what this shift means.
Medical Devices & Diagnostics
Is immune status the next wellness frontier? Inside Kirin and Immunosens’s strategy
Kirin and Immunosens are developing a urinary IgA self-testing service to visualize immune status. Find out what this changes for consumer immune monitoring.
Medical Devices & Diagnostics
What SCIEX’s Echo MS+ compatibility with ZenoTOF 8600 signals for modern drug discovery labs
SCIEX integrates Echo MS+ with ZenoTOF 8600 to reshape high-throughput mass spectrometry workflows. Find out why this matters for discovery labs.
Medical Devices & Diagnostics
Could Carterra Inc.’s Vega HT-SPR accelerate fragment and small-molecule discovery without compromising rigor
Find out how Carterra Inc.’s Vega HT-SPR platform could redefine primary screening and reshape early drug discovery workflows.
Medical Devices & Diagnostics
TRUE METRIX labeling change puts focus on how glucose meters communicate extreme-risk events
Trividia Health, Inc. has initiated a labeling correction for all TRUE METRIX blood glucose monitoring systems to update how the E-5 error code is described in owner booklets and instructions for use across multiple international markets. The change clarifies that users experiencing symptoms of high blood glucose alongside an E-5 reading must seek immediate medical
Medical Devices & Diagnostics
Rapid Medical’s DISTALS trial signals a structural shift in how medium vessel stroke may finally be treated
Rapid Medical disclosed late-breaking results from its DISTALS randomized controlled trial showing that the TIGERTRIEVER 13 thrombectomy device achieved significantly higher tissue reperfusion without symptomatic intracranial hemorrhage compared with medical management in medium vessel occlusion stroke. The data were presented at the 2026 International Stroke Conference and form the basis for a planned United States
Medical Devices & Diagnostics
Johnson & Johnson’s early OMNYPULSE data show promise, but the real test lies ahead
Johnson & Johnson has presented 12-month pilot data from the OMNY-AF study evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation at the 2026 AF Symposium. The early pilot cohort reported high acute procedural success, no procedure-related adverse events, and a 12-month freedom from atrial fibrillation rate approaching 90 percent. The
Medical Devices & Diagnostics
NMPA greenlights ZEISS ARTEVO 750 and 850, boosting China’s surgical visualization tech
ZEISS receives NMPA approval in China for ARTEVO 750 and 850 ophthalmic microscopes. Find out how these devices are shaping the future of eye surgery.